Text Size

Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients

This study has been completed.
Sponsor:
Information provided by:
North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT00792272
First received: November 14, 2008
Last updated: NA
Last verified: November 2008
History: No changes posted
  Purpose

Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients


Condition
Aspirin Resistance

Study Type: Observational
Official Title: Prevalence of Aspirin Resistance in Hemodialysis Patients

Resource links provided by NLM:

MedlinePlus related topics: Dialysis
Drug Information available for: Aspirin
U.S. FDA Resources

Further study details as provided by North Shore Long Island Jewish Health System:

Study Start Date: June 2008
Study Completion Date: November 2008
Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Detailed Description:

We will try to describe the profile of aspirin resistant patient in hemodialysis patients

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

all hemodialysis patients on aspirin

Criteria

Inclusion Criteria:

  • all hemodialysis patients on aspirin

Exclusion Criteria:

  • low platelets <100.000
  • coagulopathy, bleeding disorders
  • patient on plavix
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Suzanne El-Sayegh, staten island university hospital
ClinicalTrials.gov Identifier: NCT00792272     History of Changes
Other Study ID Numbers: 08-013
Study First Received: November 14, 2008
Last Updated: November 14, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by North Shore Long Island Jewish Health System:
aspirin resistance
aspirin resistance in hemodialysis patients

Additional relevant MeSH terms:
Aspirin
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Anti-Inflammatory Agents
Therapeutic Uses
Antirheumatic Agents
 Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Cardiovascular Agents
Hematologic Agents
Platelet Aggregation Inhibitors
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Antipyretics
Central Nervous System Agents

ClinicalTrials.gov processed this record on May 21, 2013